1. Home
  2. ACHV vs PFLT Comparison

ACHV vs PFLT Comparison

Compare ACHV & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$8.48

Market Cap

833.5M

Sector

Health Care

ML Signal

HOLD

Logo PennantPark Floating Rate Capital Ltd.

PFLT

PennantPark Floating Rate Capital Ltd.

HOLD

Current Price

$7.43

Market Cap

742.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
PFLT
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
833.5M
742.1M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
ACHV
PFLT
Price
$8.48
$7.43
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$14.67
$10.50
AVG Volume (30 Days)
1.3M
878.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
14.12%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.16
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$24.14
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$6.83
52 Week High
$8.61
$10.29

Technical Indicators

Market Signals
Indicator
ACHV
PFLT
Relative Strength Index (RSI) 69.38 53.55
Support Level $3.99 $7.03
Resistance Level $8.61 $7.67
Average True Range (ATR) 0.40 0.12
MACD 0.01 0.01
Stochastic Oscillator 90.41 70.56

Price Performance

Historical Comparison
ACHV
PFLT

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.

Share on Social Networks: